OCULAR THERAPEUTIX, INC (OCUL) Retained Earnings (Accumulated Deficit) USD 2013 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Ocular Therapeutix, Inc quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2013 to 2024.
  • Ocular Therapeutix, Inc Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was -$762 M, a 17.8% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -$762 M -$115 M -17.8% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$698 M -$80.7 M -13.1% Dec 31, 2023 10-Q 2024-05-07
Q3 2023 -$668 M -$67.1 M -11.2% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 -$668 M -$90.7 M -15.7% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 -$647 M -$88.8 M -15.9% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 -$617 M -$71 M -13% Dec 31, 2022 10-K 2024-03-11
Q3 2022 -$601 M -$59.3 M -11% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 -$577 M -$32.5 M -5.97% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 -$558 M -$22.2 M -4.14% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 -$546 M -$6.55 M -1.22% Dec 31, 2021 10-K 2023-03-06
Q3 2021 -$542 M -$88.3 M -19.5% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 -$545 M -$103 M -23.3% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 -$536 M -$131 M -32.3% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 -$539 M -$156 M -40.6% Dec 31, 2020 10-K 2022-02-28
Q3 2020 -$454 M -$96 M -26.9% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 -$442 M -$103 M -30.4% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 -$405 M -$90.8 M -28.9% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 -$384 M -$86.4 M -29.1% Dec 31, 2019 10-K 2021-03-11
Q3 2019 -$358 M -$77.8 M -27.8% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 -$339 M -$74 M -27.9% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 -$314 M -$63.3 M -25.2% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 -$297 M -$60 M -25.3% Dec 31, 2018 10-K 2020-03-12
Q3 2018 -$280 M -$55.7 M -24.8% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 -$265 M -$56.2 M -27% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 -$251 M -$61.1 M -32.2% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 -$237 M -$63.4 M -36.5% Dec 31, 2017 10-K 2019-03-07
Q3 2017 -$224 M -$63.1 M -39.2% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 -$209 M -$57.1 M -37.7% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 -$190 M -$49.9 M -35.6% Mar 31, 2017 10-Q 2017-05-05
Q4 2016 -$174 M -$44.7 M -34.6% Dec 31, 2016 10-K 2018-03-08
Q3 2016 -$161 M -$42.5 M -35.9% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 -$151 M -$44.4 M -41.5% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 -$140 M -$43 M -44.3% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 -$129 M -$39.7 M -44.4% Dec 31, 2015 10-K 2017-03-10
Q3 2015 -$119 M -$37.1 M -45.5% Sep 30, 2015 10-Q 2015-11-10
Q2 2015 -$107 M -$32.8 M -44.3% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 -$97 M Mar 31, 2015 10-Q 2015-05-15
Q4 2014 -$89.4 M -$28.6 M -47.1% Dec 31, 2014 10-K 2016-03-10
Q3 2014 -$81.5 M Sep 30, 2014 10-Q 2014-11-12
Q2 2014 -$74.2 M Jun 30, 2014 10-Q 2014-08-29
Q4 2013 -$60.8 M Dec 31, 2013 10-K 2015-03-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.